603 related articles for article (PubMed ID: 12496938)
1. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
Balla A; Sershen H; Serra M; Koneru R; Javitt DC
Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
[TBL] [Abstract][Full Text] [Related]
2. Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release.
Balla A; Koneru R; Smiley J; Sershen H; Javitt DC
Neuropsychopharmacology; 2001 Aug; 25(2):157-64. PubMed ID: 11425499
[TBL] [Abstract][Full Text] [Related]
3. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
4. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.
Takahata R; Moghaddam B
Neuropsychopharmacology; 2003 Jun; 28(6):1117-24. PubMed ID: 12700703
[TBL] [Abstract][Full Text] [Related]
5. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists.
Javitt DC; Balla A; Burch S; Suckow R; Xie S; Sershen H
Neuropsychopharmacology; 2004 Feb; 29(2):300-7. PubMed ID: 14560321
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.
Del Arco A; Mora F; Mohammed AH; Fuxe K
J Neural Transm (Vienna); 2007 Feb; 114(2):185-93. PubMed ID: 16897609
[TBL] [Abstract][Full Text] [Related]
8. Phencyclidine-induced dysregulation of dopamine response to amphetamine in prefrontal cortex and striatum.
Balla A; Hashim A; Burch S; Javitt DC; Lajtha A; Sershen H
Neurochem Res; 2001 Sep; 26(8-9):1001-6. PubMed ID: 11699927
[TBL] [Abstract][Full Text] [Related]
9. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
Jentsch JD; Taylor JR; Roth RH
Neuropsychopharmacology; 1998 Aug; 19(2):105-13. PubMed ID: 9629564
[TBL] [Abstract][Full Text] [Related]
10. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.
Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S
Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132
[TBL] [Abstract][Full Text] [Related]
11. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat.
Hertel P; Mathé JM; Nomikos GG; Iurlo M; Mathé AA; Svensson TH
Behav Brain Res; 1995 Dec; 72(1-2):103-14. PubMed ID: 8788863
[TBL] [Abstract][Full Text] [Related]
12. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex.
Lu W; Chen H; Xue CJ; Wolf ME
Synapse; 1997 Jul; 26(3):269-80. PubMed ID: 9183816
[TBL] [Abstract][Full Text] [Related]
13. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
Adams BW; Bradberry CW; Moghaddam B
Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
[TBL] [Abstract][Full Text] [Related]
14. Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats.
Kusljic S; van den Buuse M; Gogos A
J Integr Neurosci; 2022 Jan; 21(1):17. PubMed ID: 35164453
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
16. Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide.
Javitt DC; Sershen H; Hashim A; Lajtha A
Neuropsychopharmacology; 1997 Sep; 17(3):202-4. PubMed ID: 9272487
[TBL] [Abstract][Full Text] [Related]
17. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: the roles of glutamate, dopamine, acetylcholine and corticosteroids.
Griffiths MR; Cooper AJ; Barber DJ; Mitchell IJ
Brain Res; 2000 Feb; 855(1):1-10. PubMed ID: 10650124
[TBL] [Abstract][Full Text] [Related]
19. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
Jodo E
J Physiol Paris; 2013 Dec; 107(6):434-40. PubMed ID: 23792022
[TBL] [Abstract][Full Text] [Related]
20. Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.
Egerton A; Reid L; McGregor S; Cochran SM; Morris BJ; Pratt JA
Psychopharmacology (Berl); 2008 May; 198(1):37-49. PubMed ID: 18427784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
